Ami Drugs and Speciality Chemicals Baroda Customer Care Number : amidrugs.com
Company : Ami Drugs and Speciality Chemicals Pvt. Ltd.
Head Quarters : Baroda
Industry : Chemical Industry
Service/Product : Active Pharamacetical Ingridents,Drugs Ingridents,etc
| Want to comment on this post? Go to bottom of this page. |
|---|
Website : www.amidrugs.com
Customer Care Number :
Call Us : +91 22 45761000
Related : GHCL Noida Customer Queries Email ID & Number : www.customercare.gen.in/2763.html
Contact Address :
2ND Floor, Prestige Plaza,
40,Urmi Society, Urmi Char Rasta,
Productivity Road, Baroda-390 020.
Gujarat, INDIA.
TEL : 0091 265 232 3046
FAX : 0091 265 231 3523 / 305 2104
Email : mail AT amidrugs.com
Manufacturing Unit I :
Plot No.82/B, ECP Channel Road,
AT & PO. Karakhadi,
Dist. Baroda-391450
Gujarat, INDIA.
TEL : 0091 265 232 3046
FAX : 0091 265 231 3523 / 305 2104
Email : mail AT amilifesciences.com
Surat :
Ami Organics Pvt. Ltd.
Manufacturing Unit II
440/5, Road No.82,
GIDC Sachin,
Surat–394 230.
Gujarat, INDIA.
Marketing Office :
Mumbai :
305,Nitco Biz Park,3rd Floor,
Road No.16, Wagle Estate,
Thane (W) 400 604
Maharashtra, INDIA
Mobile:- +91 – 99209 87160
Customer Care : +91 22 45761000
Email:- mail AT amidrugs.com
USA :
19, Cumberland Drive
Voorhees, NJ 08043
USA
Tel. : +390395968022
Fax :+393473702257
Mr.Bhaskar Patel
Mobile No.: 856-287-2255
Email: bhaspatel AT aol.com
Europe :
Alessandro Ranzani (Sales Representative)
AMI Organics Europe
Via Ferruccio Gilera, 12
20862, Arcore (MB), Italia
Tel : +1 856 287 2255
Fax : +1 856 751 4535
Email : ale.ranzani AT amiorganics.com
For API :
Mr. Venkatesh Talanki
Call us : +91 – 99209 87160
Email Us : venkatesh AT amidrugs.com
For Contract Manufacturing :
Mr. Girish Chovatia – girish AT amidrugs.com
For Intermediate :
Mr. Naresh Patel – mail AT amiorganics.com
For API USA :
Mr. Bhaskar Patel – bhaskar.patel AT amidrugs.com
About Us :
AMI GROUP privately own company was established in 1997. Complementing the Global Healthcare effort AMI GROUP an Indian Pharma Company has reported strong initiatives in 2006 and announced firm plans for itself to emerge as an Integrated pharma company of the future company has developed a series of API and advance pharma intermediates for latest API.